In this piece, we will discuss the 12 Oversold Global Stocks to Invest In.
As the market faces persistent pressure, investors continue to debate how best to approach oversold stocks.
Appearing in an interview with CNBC on November 21, 2025, David Katz of Matrix Asset Advisors called widespread weakness a potential entry point, saying that the current correction is “much closer to ending than beginning.” He highlighted that value for investors lies in surveying a broader group, then identifying and separating stocks whose selloffs have gone too far. This way, they will be looking for stocks that are truly oversold for the wrong reasons and may therefore rebound. Amid the discussions, he pointed out Boeing, which is finally on its way to a turnaround following years of setbacks, and Fiserv, whose decline appears justified amid lowered guidance and past management concerns. With this contrast, Katz distinguished truly oversold stocks from those declining for the right reasons.
While highlighting that oversold opportunities also extend to large-cap tech stocks, he mentioned Meta, whose drastic drop is attributed to aggressive spending plans rather than weakening fundamentals. He believes the pullback offers an opportunity for investors with a six- to twelve-month horizon, as the stock’s earnings multiples remain reasonable and its AI-related relevance remains intact.
Meanwhile, on November 12, 2025, Tom Sosnoff, Founder and CEO of LossDog and former CEO of Tastytrade, appeared on CNBC, where he cautioned retail traders against chasing narratives or guessing at policy-driven rallies. Instead, he advised investors to prioritize stocks that are profitable, relatively cheap, and potentially oversold. At the same time, he cited recent market reactions, including government-backed surges and corrections in stocks like MP Materials, as reminders that share price surges could be followed by drastic declines once volatility snaps back.
With this backdrop, we will now jump to our list of the 12 oversold global stocks to invest in.
Our Methodology
To curate our list of the 12 oversold global stocks to invest in, we used the financial media sources, ETFs, and screeners to select companies with a global footprint, either via physical operations or, for technology companies, through worldwide service offerings. Next, we shortlisted oversold stocks with an RSI under 30 and a share price at least 20% below the 52-week high as of November 25, 2025. From this list, we selected stocks with the highest upside potential as of November 25, 2025. Furthermore, we ensured that these stocks have significant analyst coverage. Finally, we present our list of oversold global stocks, ranked in ascending order by each stock’s upside potential.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
12. Nutanix, Inc. (NASDAQ:NTNX)
Share Price Decline Versus 52-Week High: 29.50%
Relative Strength Index: 17.28
Upside Potential: 22.00%
Nutanix, Inc. (NASDAQ:NTNX) is included in our list of the 12 oversold global stocks to invest in.
On November 26, 2025, Nutanix, Inc. (NASDAQ:NTNX) saw Morgan Stanley’s Sanjit Singh reiterate a “Buy” rating and reduce the price target to $82. The company reported 13% YoY revenue growth in Q1 to $670.6 million. Singh noted that this growth, though slightly below expectations due to several deals with deferred start dates, does not reflect deteriorating demand. Meanwhile, the company’s continued operational strength was highlighted by the analyst, including 18% ARR growth, 17% net-new ARR expansion, maintained FY26 operating margin guidance, and a $10 million boost to free cash flow guidance. These positives drove the analyst’s bullish stance.
Meanwhile, Nutanix, Inc. (NASDAQ:NTNX) reported fiscal Q1 2026 results on November 25, which marked resilient demand for its hybrid multicloud platform. This was evident from the quarter’s bookings, which came in slightly ahead of expectations. Furthermore, free cash flow remained strong at $174.5 million, up from $151.9 million in Q1 2025. While management noted some revenue shifting from Q1 to future quarters, they emphasized that total revenue over time remains the same.
Looking ahead, Nutanix, Inc. (NASDAQ:NTNX)’s management remains optimistic, thanks to continued partner momentum driven by expanded collaborations with Dell and Microsoft. Building on this perceived momentum, the company raised its free cash flow outlook for the year. Non-GAAP net income per share (diluted) of $0.41 was recorded for the quarter, which represents a YoY increase of $0.05.
Nutanix, Inc. (NASDAQ:NTNX) is focused on delivering a unified hybrid multicloud software platform that enables over 29,000 customers worldwide to run applications and manage data seamlessly.
11. Bentley Systems, Incorporated (NASDAQ:BSY)
Share Price Decline Versus 52-Week High: 30.40%
Relative Strength Index: 26.68
Upside Potential: 41.15%
Bentley Systems, Incorporated (NASDAQ:BSY) is one of the 12 oversold global stocks to invest in.
In November, Bentley Systems, Incorporated (NASDAQ:BSY) strengthened its narrative of steady growth and shareholder returns, thanks to solid Q3 2025 results and new capital-allocation commitments.
On November 21, 2025, Bentley Systems, Incorporated (NASDAQ:BSY) declared a $0.07 per-share dividend for the fourth quarter of 2025. Alongside the dividend payment, payable on December 11, the company expanded its stock repurchase program through 2028 with authorization to repurchase up to $500 million in Class B shares and convertible notes. This expansion replaced the authorization previously set to expire in mid-2026.
Meanwhile, on November 5, 2025, Bentley Systems, Incorporated (NASDAQ:BSY) reported its Q3 2025 results. The quarter saw resilient demand across global infrastructure markets, helping revenues grow 12% YoY to $375.5 million. The revenue growth was primarily driven by 13.5% growth in subscription revenues and a 10.5% increase in ARR on a constant-currency basis. The company’s profitability also improved, with an operating margin of 22.5% and free cash flow of $110.7 million.
Discussing the business highlights for the quarter, Bentley Systems, Incorporated (NASDAQ:BSY)’s management emphasized the increasing role of AI in the company’s long-term strategy. In that context, they highlighted new Infrastructure AI capabilities, which were introduced during Bentley’s Year in Infrastructure Conference. Looking ahead, management remains optimistic about continued growth, citing strong pipelines, diversified demand, and expanding AI-driven consumption models as key drivers.
Bentley Systems, Incorporated (NASDAQ:BSY) delivers engineering software and digital twin solutions, helping global infrastructure professionals design, build, and manage resilient assets across diverse sectors.
10. Elastic N.V. (NYSE:ESTC)
Share Price Decline Versus 52-Week High: 41.49%
Relative Strength Index: 26.17
Upside Potential: 52.77%
Elastic N.V. (NYSE:ESTC) is included in our list of the 12 oversold global stocks to invest in.
As of November 27, Elastic N.V. (NYSE:ESTC) is a strong Buy with 70% analysts covering it having a Buy or equivalent rating. With a consensus 1-year average price target of $106.22, the stock has a 51.87% upside potential.
The Fly reported on November 24, 2025, that Goldman Sachs reduced its price target on Elastic N.V. (NYSE:ESTC) from $100 to $77, reiterating a “Neutral” rating. In after-hours trading, the company’s share price declined 12%, which the investment firm sees as investors’ reaction to a softer-than-expected quarterly top-line beat and a 15% decline in net new cloud revenue.
Meanwhile, Elastic N.V. (NYSE:ESTC) reported fiscal Q2 2026 results on November 20, 2025. The quarter saw revenue climb 16% YoY to $423 million and non-GAAP diluted EPS reach $0.64. Revenue growth was driven by 17% YoY growth in subscription revenue to $398 million, led by 22% YoY Elastic Cloud growth.
Elastic N.V. (NYSE:ESTC)’s management cited expanding adoption of its Search AI capabilities, new product launches (Agent Builder and Elastic Inference Service), and continued leadership recognition as key growth drivers for the performance. Surpassing top competitors, the company achieved 99.3% effectiveness across both Active Response and Passive Response in AV-Comparatives Endpoint Prevention and Response (EPR) Test 2025.
With its Search AI Platform, Elastic N.V. (NYSE:ESTC) enables organizations worldwide, including thousands of enterprises and Fortune 500 companies, to transform data into actionable insights by delivering search, observability, and security solutions.
9. Via Transportation, Inc. (NYSE:VIA)
Share Price Decline Versus 52-Week High: 35.22%
Relative Strength Index: 29.79
Upside Potential: 54.61%
Via Transportation, Inc. (NYSE:VIA) is one of the 12 oversold global stocks to invest in.
As of November 27, Via Transportation, Inc. (NYSE:VIA) is a consensus Buy with over 80% analysts covering it having a Buy, Strong Buy, or equivalent rating. With a consensus 1-year average price target of $56.40, the stock has a 64.53% upside potential.
On November 19, 2025, Via Transportation, Inc. (NYSE:VIA) was revisited by Wells Fargo’s Michael Turrin, who reiterated a “Buy” rating with a $60 price target.
This was shortly preceded by the company’s Q3 2025 results, announced on November 13, 2025. The quarter was marked by 32% YoY revenue growth and $439 million in platform annual revenue run rate. During the quarter, new customers were added, taking the total to 713 on its platform, alongside expansion of services with existing clients. Leading the revenue growth, U.S. government revenue rose by $26.5 million, or 34% YoY, thanks to multiyear contracts and strong adoption of its TransitTech platform across multiple verticals.
Management noted that the company’s performance in the quarter reflected continued innovation, the rollout of AI-powered transit planning tools, an upgraded dispatching interface, and self-service solutions, which enhanced network optimization and operational efficiency. Furthermore, Via Transportation, Inc. (NYSE:VIA)’s international expansion, particularly in the U.K., benefited from the government taking control of transit networks. Moreover, management highlighted its commitment to modernizing mobility, seen through its strategic partnerships, including its partnership with Waymo to integrate autonomous vehicles into public transit. Despite the positives, the company reported adjusted net loss of $9.68 million.
Looking ahead, Via Transportation, Inc. (NYSE:VIA) remains well-positioned to capitalize on its estimated $82 billion serviceable addressable market, thanks to high customer stickiness, scalable R&D, and a growing footprint in both domestic and international markets.
With its AI-driven software and services platform, Via Transportation, Inc. (NYSE:VIA) helps cities and transit agencies worldwide design, operate, and optimize modern public transportation networks.
8. Arcellx, Inc. (NASDAQ:ACLX)
Share Price Decline Versus 52-Week High: 24.27%
Relative Strength Index: 28.79
Upside Potential: 54.96%
Arcellx, Inc. (NASDAQ:ACLX) is included in our list of the 12 oversold global stocks to invest in.
On November 25, 2025, Arcellx, Inc. (NASDAQ:ACLX) saw Morgan Stanley’s Judah Frommer reiterate a “Buy” rating. The investment firm’s bullish stance stemmed from the company’s CAR-T therapy’s safety profile, potential for high minimal residual disease (MRD) negativity rates, and differentiation from existing treatments like Carvykti. The analyst noted that the therapy, aimed at treating multiple myeloma (MM), remains a key growth driver for the company.
Management remains confident that CAR-T therapy will capture a substantial share of the 2L-3L global MM market, particularly within large healthcare enterprises and academic centers. Moreover, the analyst highlighted the upcoming data presentations at the ASH meeting, which are expected to provide further validation for anito-cel’s durability and efficacy. Together, these factors are expected to drive upside in the stock.
Meanwhile, on November 5, 2025, Arcellx, Inc. (NASDAQ:ACLX) reported its Q3 2025 results. The company closed the quarter with $576 million in cash, providing a runway into 2028. Due to completion of dosing in the iMMagine-1 trial, collaboration revenue fell from $26 million in Q3 2024 to $4.9 million. Net loss for the quarter was $55.8 million, widening from $25.9 million in Q3 2024.
Arcellx, Inc. (NASDAQ:ACLX) is focused on the development of innovative CAR-T and cell therapies for cancer and incurable diseases.
7. Axon Enterprise, Inc. (NASDAQ:AXON)
Share Price Decline Versus 52-Week High: 40.30%
Relative Strength Index: 26.76
Upside Potential: 55.51%
Axon Enterprise, Inc. (NASDAQ:AXON) is one of the 12 oversold global stocks to invest in.
As of November 27, Axon Enterprise, Inc. (NASDAQ:AXON) stock is a consensus Buy with 90% of analysts covering it having a Buy or equivalent rating. With a consensus 1-year average price target of $822.50, the stock has a 54.27% upside potential.
On November 7, 2025, CFRA upgraded Axon Enterprise, Inc. (NASDAQ:AXON) from “Buy” to “Strong Buy.” However, the investment firm reduced its price target from $992 to $785. The price adjustment reflects a multiple of 79.0x on its 2027 EPS estimate, which is below the stock’s trailing 12-month average forward price-to-earnings ratio of 108.5x and aligned with peers.
Following the company’s Q3 earnings release, the investment firm reduced EPS estimates to $6.32 for 2025, $7.79 for 2026, and $9.94 for 2027, reflecting the company’s earnings miss in the quarter. This comes despite the company raising its full-year 2025 revenue guidance to roughly $2.74 billion, translating into 31% growth.
Meanwhile, on November 4, 2025, Axon Enterprise, Inc. (NASDAQ:AXON) announced its definitive agreement to acquire Carbyne. With this acquisition, the company will merge Carbyne’s cloud-native emergency communications platform with its own AI-driven insights. This will result in Axon 911, a next-generation system that connects callers, dispatchers, and responders. The companies are expected to close the transaction in the first quarter of 2026.
CFRA cited the company’s $5 billion expansion of its total addressable market from its Carbyne and Prepared acquisitions and expressed optimism about its strengthened international momentum, driven by a major European cloud deal.
Axon Enterprise, Inc. (NASDAQ:AXON), a global public safety technology company, provides connected devices, digital evidence systems, and AI-enhanced tools for emergency responses and security operations.
6. Varonis Systems, Inc. (NASDAQ:VRNS)
Share Price Decline Versus 52-Week High: 49.19%
Relative Strength Index: 27.12
Upside Potential: 62.09%
Varonis Systems, Inc. (NASDAQ:VRNS) is one of the 12 oversold global stocks to invest in.
On November 19, Varonis Systems, Inc. (NASDAQ:VRNS) was reported to have reached its 52-week low of $32.01. The company’s share price has declined 27.19% so far in 2025 and 35.18% over the past year as of November 26. This share price plunge reflects a challenging period for the company.
The decline began following Varonis Systems, Inc. (NASDAQ:VRNS)’s Q3 2025 results announcement on October 28, with the share price declining 48.67% between October 28 and 29. With customers migrating to the SaaS platform, term license subscription and maintenance revenues declined, prompting mixed sentiment among investors.
Amid this selloff, William Blair’s Jason Ader reiterated a “Buy” rating on October 29. The analyst expressed confidence in the company’s historical sales execution and its ability to remain resilient through business model transitions. The analyst views the stock’s recent drop as an overreaction by investors, citing better-than-expected term renewals reported by Varonis Systems, Inc. (NASDAQ:VRNS) earlier in the year. Without dismissing potential structural challenges and rising competition, the analyst believes the current dip is an opportunity for investors rather than a signal of systemic issues.
Meanwhile, Varonis Systems, Inc. (NASDAQ:VRNS)’s Q3 2025 earnings report revealed total revenue of $161.6 million, up from $148.1 million in Q3 2024. Despite total revenue increasing, the company noted softness in the Term License Subscription and Maintenance & Services segments.
Term License Subscription fell from $68.8 million in Q3 2024 to $24.8 million, driven by customers converting to the company’s SaaS platform. On the other hand, Maintenance & Services revenue fell from $21.5 million in Q3 2024 to $10.9 million, also driven by customer migration to its SaaS platform. Varonis Systems, Inc. (NASDAQ:VRNS)’s non-GAAP EPS (diluted) for the quarter reached $0.06, down from $0.10 in Q3 2024.
Varonis Systems, Inc. (NASDAQ:VRNS), a leading AI-powered data security company, protects critical information across SaaS, IaaS, and hybrid cloud environments for organizations worldwide.
5. e.l.f. Beauty, Inc. (NYSE:ELF)
Share Price Decline Versus 52-Week High: 52.24%
Relative Strength Index: 28.98
Upside Potential: 68.78%
e.l.f. Beauty, Inc. (NYSE:ELF) is included in our list of the 12 oversold global stocks to invest in.
On November 25, 2025, e.l.f. Beauty, Inc. (NYSE:ELF) saw Morgan Stanley’s Dara Mohsenian reaffirm a “Buy” rating with a $121 price target. The investment firm’s bullish stance reflects the company’s strong market performance and growth potential, as evidenced by U.S. scanner data. The data revealed 15.3% YoY sales growth over the last two weeks (as of the original reporting date).
The most recent week saw a 13.8% increase, supported by a 15.7% rise in weighted average pricing. In the last week, the data also showed the company’s 85-basis-point YoY gain in market share. At the same time, velocity and total distribution points (TDP) saw improvement, with velocity up 11.8% YoY over the past four months. With this data, e.l.f. Beauty, Inc. (NYSE:ELF) demonstrated its consistent competitive strength.
Meanwhile, on November 20, 2025, e.l.f. Beauty, Inc. (NYSE:ELF) announced its international expansion into the Gulf Cooperation Council (GCC) region, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE. By launching itself in the GCC through partner Sephora, one of the world’s largest beauty retailers, the company looks to fuel its future growth. The region boasts some of the highest social media penetration rates in the world. Among regions without a retail presence, the GCC ranks number one on the company’s list of most requested regions, with social mentions over 38% in the region. With this move, e.l.f. Beauty, Inc. (NYSE:ELF) marks its first entry into the region, building on its goal of making beauty accessible globally while complementing its strong U.S. performance.
e.l.f. Beauty, Inc. (NYSE:ELF) is focused on creating accessible, clean, vegan cosmetics and skincare products.
4. Wix.com Ltd. (NASDAQ:WIX)
Share Price Decline Versus 52-Week High: 61.77%
Relative Strength Index: 21.03
Upside Potential: 77.56%
Wix.com Ltd. (NASDAQ:WIX) is one of the 12 oversold global stocks to invest in.
As of November 27, Wix.com Ltd. (NASDAQ:WIX) is a consensus Buy with over 90% analysts covering it having a Buy, Strong Buy, or equivalent rating. With a consensus 1-year average price target of $167.76, the stock has a 75.17% upside potential.
On November 24, 2025, UBS reiterated its “Buy” rating on Wix.com Ltd. (NASDAQ:WIX) with a $170 price target, which shortly followed the company’s Q3 2025 results announcement on November 19.
In the third quarter, Wix.com Ltd. (NASDAQ:WIX) reported 14% YoY revenue growth, taking it to $505.2 million. The revenue growth was driven by Creative Subscriptions revenue of $356.2 million, up 12% YoY, and Business Solutions revenue of $149.0 million, up 18% YoY. While non-GAAP net income hit $100.2 million, or $1.68 per diluted share, the company recorded a GAAP net loss of $0.6 million. The quarter saw a healthy demand across both core offerings and the Base44 platform, with total bookings rising 14% to $514.5 million.
Management expressed confidence in its Base44 platform, whose top-line growth is surpassing expectations, and therefore prompting accelerated marketing investments with strong returns on investment. Wix.com Ltd. (NASDAQ:WIX)’s CFO, Lior Shemesh, reaffirmed that strategic investments will solidify the platform as a key growth driver in 2026. The platform’s growth potential also caught the attention of Needham’s Bernie McTernan, who reiterated a “Buy” rating on November 19, 2025. Despite acknowledging that it is currently too early to predict Base44 as a long-term revenue driver, the analyst believes the high-end projections translate into significant future upside.
The quarter also saw Wix.com Ltd. (NASDAQ:WIX) executing $175 million in share repurchases, updating its full-year revenue guidance to $1.99-2.00 billion, and projecting bookings at $2.060-2.078 billion. Management anticipates a meaningful contribution from Base44, alongside stable core growth.
Wix.com Ltd. (NASDAQ:WIX), a global platform, enables users to create and manage digital experiences. It helps businesses, creators, and enterprises scale online with its AI-powered website builder and Base44 no-code applications.
3. CoreWeave, Inc. (NASDAQ:CRWV)
Share Price Decline Versus 52-Week High: 61.88%
Relative Strength Index: 29.50
Upside Potential: 86.73%
CoreWeave, Inc. (NASDAQ:CRWV) is included in our list of the 12 oversold global stocks to invest in.
Recently, Cathie Wood’s ARK Invest ETFs continued to expand their stake in CoreWeave Inc. (NASDAQ:CRWV). In its November 25 filings, ARK acquired 396,198 shares worth $28.2 million. This was preceded by previous day’s purchase of 437,345 shares valued at $31.3 million.
The bullish activity was also seen on Friday, November 21, when ARK purchased 350,734 shares, equivalent to $24.27 million. Cathie Wood’s sentiment surrounding CoreWeave, Inc. (NASDAQ:CRWV) remained unchanged despite the 3% share price decline on that day amid concerns about the company’s reliance on Nvidia GPUs. This reflects ARK’s rising conviction in the AI-focused cloud infrastructure firm.
Prior to this bullish activity, CoreWeave, Inc. (NASDAQ:CRWV) announced a global partnership with CrowdStrike on November 5, 2025, at Fal.Con Europe 2025. With this move, the company will integrate its high-performance AI Cloud with CrowdStrike’s Falcon platform, with the aim of protecting complex AI workloads. CEOs of both companies expressed excitement about the collaboration’s potential to enable AI leaders to build, train, and deploy AI securely and at scale, while leveraging Nvidia’s infrastructure. Looking ahead, this partnership will position CoreWeave well to be at the forefront of the agentic era.
By combining high-performance technology and technical expertise, CoreWeave, Inc. (NASDAQ:CRWV)’s AI-focused cloud infrastructure helps innovators scale AI securely.
2. Zai Lab Limited (NASDAQ:ZLAB)
Share Price Decline Versus 52-Week High: 55.12%
Relative Strength Index: 18.61
Upside Potential: 148.69%
Zai Lab Limited (NASDAQ:ZLAB) is one of the 12 oversold global stocks to invest in.
As of November 27, Zai Lab Limited (NASDAQ:ZLAB) is a consensus Buy with over 90% analysts covering it having a Buy, Strong Buy, or equivalent rating. With a consensus 1-year average price target of $49.49, the stock has a 147.82% upside potential.
On November 7, 2025, Zai Lab Limited (NASDAQ:ZLAB) saw UBS reiterate a “Buy” rating on the company’s Hong Kong-listed shares with a HK$33.50 price target.
Just a day earlier, Zai Lab Limited (NASDAQ:ZLAB) announced its Q3 2025 results, reflecting continued momentum across its commercial and pipeline programs. The company’s product revenue grew 13.0% YoY to $115.4 million. Revenue growth was driven by NUZYRA and XACDURO, partially offset by softer ZEJULA sales. With its sales reaching $27.7 million, VYVGART experienced extended therapy duration and increased market share despite a voluntary $2.4 million price adjustment for Hytrulo. While adjusted loss from operations saw improvement to $28.0 million, net loss narrowed to $36.0 million, or $0.03 per share.
Recapping the developments that took place during the quarter, management cited Zocilurtatug Pelitecan (zoci), which advanced into pivotal studies in second-line extensive-stage small cell lung cancer. Furthermore, they highlighted povetacicept’s progression in IgA nephropathy trials. Management also expressed optimism about VYVGART’s increasing adoption in generalized myasthenia gravis. The quarter also saw KarXT preparation in schizophrenia progressing alongside favorable new national treatment guidelines. With robust expansion of its global pipeline, Zai Lab Limited (NASDAQ:ZLAB) looked ahead with confidence, reaffirming full-year 2025 revenue guidance of at least $460 million, driven by disciplined execution and growing commercial presence in China.
Zai Lab Limited (NASDAQ:ZLAB), a research-based, commercial-stage biopharmaceutical company, focuses on innovative therapies for oncology, immunology, neuroscience, and infectious diseases.
1. Strategy Inc. (NASDAQ:MSTR)
Share Price Decline Versus 52-Week High: 62.34%
Relative Strength Index: 26.92
Upside Potential: 200.37%
Strategy Inc. (NASDAQ:MSTR) is included in our list of the 12 oversold global stocks to invest in.
Amid ongoing crypto market turbulence that is instilling fears of liquidation among investors, Strategy Inc. (NASDAQ:MSTR) felt the need to reassure investors about its debt-service capabilities. Thus, by launching a new credit rating dashboard on November 26, 2025, according to The Fly, the company reassured investors, emphasizing that it maintains a dividend payment runway of over 70 years, even if Bitcoin (BTC-USD) prices do not rebound. Bitcoin prices have seen a 19.98% decline in the past month, as of the time of writing. With this move, the company aimed to calm fears that the BTC price plunge could trigger liquidation for digital asset treasury companies.
However, market conditions remain challenging for Strategy Inc. (NASDAQ:MSTR), with its share price plunging over 60% from last year’s peak, as of the close of the same day. Meanwhile, Bitcoin declined from its 52-week high of $126,198 in October 2025, reaching close to $80,000 (-36%) on November 21.
According to a November 26 TipRanks report, JPMorgan warned investors that the company is facing a risk of being removed from major equity indexes. This could potentially result in $2.8 billion MSCI-linked outflows, alongside additional selling pressure. The firm believes the current drop is like previous major declines, including a 60% drop in early 2021 and an 84% drop after November 2021.
Amid this volatility, however, Bernstein’s Gautam Chugani reiterated a “Buy” rating on Strategy Inc. (NASDAQ:MSTR) with a $600 price target on November 17.
Leveraging equity, debt, and operations, Strategy Inc. (NASDAQ:MSTR), the world’s largest bitcoin treasury company, strategically accumulates Bitcoin and offers digital capital exposure to investors.
While we acknowledge the potential of MSTR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MSTR and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Small-Cap Biotech Stocks to Buy According to Analysts and 12 Best Commodity Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
